Ultragenyx Pharmaceutical
Lobbying group · Jul 2025 – Sep 2026
Ultragenyx Pharmaceutical spent $1.1M lobbying the federal government (Jul 2025 – Sep 2026), mostly on health care, budget & spending, medicare & medicaid. It used 7 lobbyists, including people who worked for 4 members of Congress.
- Spent on lobbying
- $1.1M
- Lobbyists
- 7
- Bills lobbied
- 6
- Issues
- 5
Spending by quarter
- 2025 Q3$140K
- 2025 Q4$130K
- 2026 Q1$440K
- 2026 Q2$390K
Issues lobbied
- Health care
- Budget & spending
- Medicare & Medicaid
- Media
- Government operations
Bills lobbied on
- S. 9323 reports
- H.R. 1262: Give Kids a Chance Act of 20253 reports
- H.R. 1: One Big Beautiful Bill Act1 report
- S. 7521 report
- H.R. 1509: Accelerating Kids’ Access to Care Act of 20251 report
- H.R. 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agency…1 report
Lobbying firms hired
- Ultragenyx Pharmaceutical Inc.$1.1M
- Mehlman Consulting, Inc.$240K
- Miller Strategies, LLC$140K
- Alpine Group Partners, LLC.$100K
- Aviva Strategies (Fka Mgb Consulting)$76K
- Forbes-Tate$40K
Lobbyists who worked in Congress
- Earl Flood
Dep. CoS, LD (Rep. Robin Kelly); Health Pol Adv, Csl (Rep. Terri Sewell); Csl (Rep. Cedric Richmond); Pol Aide (Sen…Robin L. Kelly (D-IL) - Earl Flood
Dep. CoS, LD (Rep. Robin Kelly); Health Pol Adv, Csl (Rep. Terri Sewell); Csl (Rep. Cedric Richmond); Pol Aide (Sen…Terri A. Sewell (D-AL) - Natalie Mcintyre
Special Assistant to the President, Office of Legislative Affairs; Sen. Bill Hagerty Legislative Director; OMB Deputy…Bill Hagerty (R-TN) - Shayne Woods
Senior Legislative Assistant, Sen. Tim Scott; Senior Policy Advisor, Rep. Gus BilirakisGus M. Bilirakis (R-FL)
Agencies contacted
- House Of Representatives · 28
- Senate · 28
- Health & Human Services, Dept of (Hhs) · 14
- Office of Management & Budget (Omb) · 8
- Food & Drug Administration (Fda) · 2
- Centers For Medicare and Medicaid Services (Cms) · 1
Related
Filings
- 2026 Q2 report$60K
- 2026 Q2 report$60K
- 2026 Q2 report$390K
- 2026 Q2 report$30K
- 2026 Q2 report$140K
From Lobbying Disclosure Act reports filed with the Senate and House.
Cite or embed this page
Capitol Receipts, “Ultragenyx Pharmaceutical: Lobbying Spending, Issues & Bills,” https://www.capitolreceipts.com/lobbying/cultragenyxpharmaceutical/ultragenyx-pharmaceutical (accessed 2026-10-17).